| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1836 | 2016 |
| Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways RP Nair, KC Duffin, C Helms, J Ding, PE Stuart, D Goldgar, ... Nature genetics 41 (2), 199-204, 2009 | 1627 | 2009 |
| Phase 3 studies comparing brodalumab with ustekinumab in psoriasis M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ... New England Journal of Medicine 373 (14), 1318-1328, 2015 | 858 | 2015 |
| Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis CT Jordan, L Cao, EDO Roberson, S Duan, CA Helms, RP Nair, KC Duffin, ... The American Journal of Human Genetics 90 (5), 796-808, 2012 | 401 | 2012 |
| Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants LC Tsoi, PE Stuart, C Tian, JE Gudjonsson, S Das, M Zawistowski, ... Nature communications 8 (1), 15382, 2017 | 355 | 2017 |
| A phase 2 trial of guselkumab versus adalimumab for plaque psoriasis KB Gordon, KC Duffin, R Bissonnette, JC Prinz, Y Wasfi, S Li, YK Shen, ... New England Journal of Medicine 373 (2), 136-144, 2015 | 345 | 2015 |
| Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture PE Stuart, RP Nair, LC Tsoi, T Tejasvi, S Das, HM Kang, E Ellinghaus, ... The American Journal of Human Genetics 97 (6), 816-836, 2015 | 335 | 2015 |
| The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) PS Helliwell, O FitzGerald, J Fransen, DD Gladman, GG Kreuger, ... Annals of the rheumatic diseases 72 (6), 986-991, 2013 | 328 | 2013 |
| International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials AM Orbai, M De Wit, P Mease, JA Shea, L Gossec, YY Leung, W Tillett, ... Annals of the rheumatic diseases 76 (4), 673-680, 2017 | 291 | 2017 |
| Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 LC Coates, ER Soriano, N Corp, H Bertheussen, K Callis Duffin, ... Nature Reviews Rheumatology 18 (8), 465-479, 2022 | 265 | 2022 |
| Consensus guidelines for the management of plaque psoriasis S Hsu, KA Papp, MG Lebwohl, J Bagel, A Blauvelt, KC Duffin, J Crowley, ... Archives of dermatology 148 (1), 95-102, 2012 | 247 | 2012 |
| Obesity in early adulthood as a risk factor for psoriatic arthritis R Soltani-Arabshahi, B Wong, BJ Feng, DE Goldgar, KC Duffin, ... Archives of dermatology 146 (7), 721-726, 2010 | 219 | 2010 |
| Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility X Yin, HQ Low, L Wang, Y Li, E Ellinghaus, J Han, X Estivill, L Sun, X Zuo, ... Nature communications 6 (1), 6916, 2015 | 214 | 2015 |
| From the Medical Board of the National Psoriasis Foundation: treatment targets for plaque psoriasis AW Armstrong, MP Siegel, J Bagel, EE Boh, M Buell, KD Cooper, ... Journal of the American Academy of Dermatology 76 (2), 290-298, 2017 | 210 | 2017 |
| Multiple Loci within the major histocompatibility complex confer risk of psoriasis BJ Feng, LD Sun, R Soltani-Arabshahi, AM Bowcock, RP Nair, P Stuart, ... PLoS genetics 5 (8), e1000606, 2009 | 178 | 2009 |
| Genetics of psoriasis and psoriatic arthritis: update and future direction KC Duffin, V Chandran, DD Gladman, GG Krueger, JT Elder, P Rahman The Journal of Rheumatology 35 (7), 1449-1453, 2008 | 149 | 2008 |
| microRNAs in psoriasis JE Hawkes, GH Nguyen, M Fujita, SR Florell, KC Duffin, GG Krueger, ... Journal of Investigative Dermatology 136 (2), 365-371, 2016 | 146 | 2016 |
| Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial NN Mehta, DB Shin, AA Joshi, AK Dey, AW Armstrong, KC Duffin, ... Circulation: Cardiovascular Imaging 11 (6), e007394, 2018 | 138 | 2018 |
| A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized … A Blauvelt, K Papp, A Gottlieb, A Jarell, K Reich, C Maari, KB Gordon, ... British Journal of Dermatology 182 (6), 1348-1358, 2020 | 137 | 2020 |
| Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis J Chung, KC Duffin, J Takeshita, DB Shin, GG Krueger, AD Robertson, ... Journal of the American Academy of Dermatology 71 (4), 623-632, 2014 | 134 | 2014 |
